Ivo Djidrovski

Ivo Djidrovski

Auto-generated profile, based on publicly available information

Ivo Djidrovski

Institute of Risk Assessment Sciences (IRAS), Utrecht University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2026 in Archives of Toxicology
Verified
Journal Article
Open access
PDF file
TGTimothy W. Gant
Timothy W. Gant
ABAlistair Boxall
Alistair Boxall
DBDaniel Burgwinkel
Daniel Burgwinkel
Maryam Zare JeddiMaryam Zare Jeddi
Maryam Zare Jeddi
IDIvo Djidrovski
Ivo Djidrovski
DRDavid Rouquié
David Rouquié
Artificial Intelligence (AI) is increasingly influencing chemical risk assessment, enabling faster, more comprehensive, and potentially more ethical assessments. The application of AI in chemical risk assessment refers to both generative and predictive algorithms encompassing machine learning, to analyse complex chemical, biological, and environmental data and provide insights into adverse effect potential for humans and ecosystems. AI systems support the prediction of chemical hazards, exposure levels, and adverse effects by learning from experimental results, mechanistic models, and regulatory datasets, thereby enhancing the efficiency of safety evaluations. In October 2024, ECETOC held an international workshop, with experts from academia, industry, and regulatory bodies, to reflect upon the historical challenges in integrating multidimensional omics technologies into chemical regulation and explore the current capabilities and future potential of AI in toxicology and regulatory science. Discussions emphasised that implementation of Findable, Accessible, Interoperable, and Reusable (FAIR) data principles is not just a best practice but rather a prerequisite for building transparent, reliable, and unbiased AI systems. The reliability of AI in producing scientifically valid and socially responsible outcomes depends fundamentally on the availability of FAIR data. However, ensuring trustworthiness also requires robust governance frameworks that go beyond data and human oversight. Critical enablers of responsible AI in chemical risk assessment are rigorous governance, explainability, fit-for-purpose applications, and human oversight. ECETOC supports the development of flexible and iterative frameworks advancing development, validation, transparency, accountability, and trust in AI applications in chemicals regulation.

9 December 2025 in Computational Toxicology
Verified
Journal Article
Open access
IDIvo Djidrovski
Ivo Djidrovski
RPRaymond Pieters
Raymond Pieters
JLJuliette Legler
Juliette Legler
MTMarc Teunis
Marc Teunis

9 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
IDIvo Djidrovski
Ivo Djidrovski
Computational toxicology increasingly relies on evidence, high-throughput screening, predictive (Q)SAR, adverse outcome pathways (AOPs), physiologically based kinetic (PBK/PBPK) models, and exposure databases to support integrated approaches to testing and assessment (IATA). Yet the practical workflow remains fragmented across heterogeneous tools, data formats, and licensing regimes. Large language models (LLMs) can lower the interface barrier, but free-text interaction alone is insufficient for regulatory-grade science: it is difficult to audit, difficult to reproduce, and prone to overconfident errors. Here we introduce ToxMCP, a collection of Model Context Protocol (MCP) servers designed as a guardrailed, federated integration layer for reproducible computational toxicology. ToxMCP wraps toxicology-relevant capabilities, including chemical identity and regulatory context (EPA CompTox), rapid ADMET profiling (ADMETlab 3.0), mechanistic pathway retrieval and structuring (AOP knowledge services), quantitative read-across workflows (OECD QSAR Toolbox), and mechanistic PBPK simulation (Open Systems Pharmacology Suite), as typed tools with explicit inputs/outputs, provenance bundles, and policy hooks (e.g., applicability domain checks, critical-action confirmation, and role-based access control). We demonstrate how natural-language risk questions can be compiled into auditable tool invocations, returning mechanistic metrics such as tissue AUC/Cmax, sensitivity curves, and conservative points of departure. We further outline an evaluation protocol for measuring computational reproducibility, task throughput, and scientific utility across multi-tool toxicology tasks. ToxMCP reframes ‘LLMs for toxicology’ from conversational summarizers into accountable orchestrators of established scientific kernels, enabling faster iteration while preserving the evidentiary structure expected in regulatory and academic settings. Graphical

12 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MCMarie Corradi
Marie Corradi
IDIvo Djidrovski
Ivo Djidrovski
LLLuiz Carlos Maia Ladeira
Luiz Carlos Maia Ladeira
BSBernard Staumont
Bernard Staumont
AVAnouk Verhoeven
Anouk Verhoeven
MOMarek Ostaszewski
Marek Ostaszewski
As biomedical knowledge keeps growing, resources storing available information multiply and grow in size and complexity. Such resources can be in the format of molecular interaction maps, which represent cellular and molecular processes under normal or pathological conditions. However, these maps can be complex and hard to navigate, especially to novice users. Large Language Models (LLMs), particularly in the form of agentic frameworks, have emerged as a promising technology to support this exploration. In this article, we describe a user-driven process of prototyping, development, and user testing of Llemy, an LLM-based system for exploring these molecular interaction maps. By involving domain experts from the very first prototyping in the form of a hackathon and collecting both fine-grained and general feedback on more refined versions, we were able to evaluate the perceived utility and quality of the developed system, in particular for summarising maps and pathways, as well as prioritise the development of future features. We recommend continued user-driven development and benchmarking to keep the community engaged. This will also facilitate the transition towards open-weight LLMs to support the needs of the open research environment in an ever-changing technology landscape.

7 January 2026 in Bioinformatics Advances
Verified
Journal Article
Open access
MCMarie Corradi
Marie Corradi
IDIvo Djidrovski
Ivo Djidrovski
LLLuiz Carlos Maia Ladeira
Luiz Carlos Maia Ladeira
BSBernard Staumont
Bernard Staumont
AVAnouk Verhoeven
Anouk Verhoeven
MOMarek Ostaszewski
Marek Ostaszewski
Summary: As biomedical knowledge keeps growing, resources storing available information multiply and grow in size and complexity. Such resources can be in the format of molecular interaction maps, which represent cellular and molecular processes under normal or pathological conditions. However, these maps can be complex and hard to navigate, especially to novice users. Large language models (LLMs), particularly in the form of agentic frameworks, have emerged as a promising technology to support this exploration. In this article, we describe a user-driven process of prototyping, development, and user testing of Llemy, an LLM-based system for exploring these molecular interaction maps. By involving domain experts from the very first prototyping in the form of a hackathon and collecting both fine-grained and general feedback on more refined versions, we were able to evaluate the perceived utility and quality of the developed system, in particular for summarizing maps and pathways, as well as prioritize the development of future features. We recommend continued user-driven development and benchmarking to keep the community engaged. This will also facilitate the transition towards open-weight LLMs to support the needs of the open research environment in an ever-changing technology landscape.